Head-to-head · computed 2026-08-11
bmiMD vs Mochi Health
bmiMD: bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules. Mochi Health: Mochi separates a $79/month clinical membership ($39 first month in some states) from flat medication pricing — $99/month semaglutide at any dose and $199/month tirzepatide at any dose — which makes its all-in cost easy to compute and its structure one of the most transparent in the category.
Tirzepatide
| bmiMD | Mochi Health | |
|---|---|---|
| All-in maintenance | $179/mo | $278/mo |
| Best plan rate | $139/mo | $278/mo |
| 12-month total | $1,668 | $3,336 |
| Status | Reported · 2026-07-14 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, bmiMD's $179 a month undercuts Mochi Health's $278 by $99 a month at the 10 mg/wk maintenance basis — $1,188 across a year. bmiMD's figure is reported (captured 2026-07-14) and Mochi Health's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
bmiMD's tirzepatide ladder runs $179 a month billed monthly, $159 a month on a three-month plan, $149 a month on a six-month plan, and $139 a month on a twelve-month plan. Mochi Health's runs $278 a month billed monthly. On the twelve-month basis bmiMD's $1,668 beats Mochi Health's $3,336 by $1,668 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| bmiMD | Mochi Health | |
|---|---|---|
| All-in maintenance | $129/mo | $178/mo |
| Best plan rate | $99/mo | $178/mo |
| 12-month total | $1,188 | $2,136 |
| Status | Reported · 2026-07-14 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, bmiMD's $129 a month undercuts Mochi Health's $178 by $49 a month at the 2.4 mg/wk maintenance basis — $588 across a year. bmiMD's figure is reported (captured 2026-07-14) and Mochi Health's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
bmiMD's semaglutide ladder runs $129 a month billed monthly, $119 a month on a three-month plan, $109 a month on a six-month plan, and $99 a month on a twelve-month plan. Mochi Health's runs $178 a month billed monthly. On the twelve-month basis bmiMD's $1,188 beats Mochi Health's $2,136 by $948 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
bmiMD carries no membership fee against Mochi Health's $79 a month — $948 a year of structural cost before any medication ships, which is why this site prices everything all-in.
Structure, side by side
bmiMD
- MembershipNone
- Dose policyFlat — same price at every dose, across all plan lengths
- CommitmentMonthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose
- CancellationPer provider terms; confirm cancellation policy at enrollment
- PharmacyNamed 503A pharmacy partner (specific pharmacy not publicly identified on pricin
Mochi Health
- Membership$79/mo
- Dose policyDose-flat medication pricing; membership billed separately
- CommitmentMonth-to-month
- CancellationCancel anytime before renewal
- PharmacyPartner 503A/503B pharmacies
What our desk is watching on each
bmiMD: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.
Mochi Health: Advertising leads with the medication price; the $79 membership is the number people miss. Eli Lilly named Mochi in 2025 personalized-dosing litigation; the company continues to operate.
Questions people ask
Is bmiMD or Mochi Health cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does bmiMD vs Mochi Health miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do bmiMD and Mochi Health cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $1,668 at bmiMD and $3,336 at Mochi Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: bmiMD · Mochi Health. Official sites: bmiMD ↗ · Mochi Health ↗. Nothing here is medical advice.